Arcturus therapeutics updates data from arct-154 and arct-165 booster clinical trial demonstrating robust neutralizing antibody responses to sars-cov-2 and several variants

San diego--(business wire)---- $arct #clinicaltrial--arcturus updates data from arct-154 and arct-165 booster clinical trial demonstrating robust neutralizing antibody responses to sars-cov-2

ARCT Ratings Summary

ARCT Quant Ranking